# Nanoviricides, Inc.: Form 8-K, filed Sep 1, 2023

- Company: [Nanoviricides, Inc.](/companies/nnvc.md) (CIK 1379006)
- Form: 8-K
- Filed: 2023-09-01
- Accepted by EDGAR: Sep 1, 2023, 20:46 ET
- Period: 2023-08-29
- Accession: 0001104659-23-097802
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1379006/000110465923097802/tm2325384d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1379006/000110465923097802/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1379006/000110465923097802/tm2325384d1_8k.htm

Filed Sep 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-097802. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.